AcuFocus
AqueSys
Cellutions
Cerebral Vascular Applications
HalScion
LipoSonix  
NeoVista
Neuronetics
NovaLign




AcuFocus, Inc.

Date Founded
2001

Innovation
AcuFocus is developing a proprietary implant to treat presbyopia, a loss of near visual acuity that occurs naturally as part of the aging process. The market is comprised of most of the population over age 45, a patient population with high disposable incomes and a strong demand for better visual acuity.

Funding
The company has completed A, B, C and D rounds of funding, raising $63.4 million.

Contact
32 Discovery, Suite 200
Irvine, CA 92618
949.585.9511 phone
949.585.9545 fax

www.acufocus.com

 



Overview : Portfolio : Funding : Join Our Team : Contact Us